PlexusDx includes personalized patient support for all patients starting semaglutide injection ($189/mo) or other GLP-1 therapies
Weight Management Research When combined with dietary protocols, this tirzepatide research peptide is investigated for its potential role in sustainable weight maintenance strategies, showing superior results compared to single-receptor alternatives
It brightens the complexion, combats oxidative stress, and adds radiance
4 For example, ADA and KDIGO joint group has recommended that for patients with T2DM and CKD who do not achieve their glycemic target with metformin and/or an SGLT2i or cannot use them, a GLP-1RAs with proven cardiovascular benefit is recommended
The Ozempic Lawsuit was officially consolidated into multidistrict litigation (MDL) in early 2024, as the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation (MDL 3094)
Explore the Akkermansia Microbiome Guide